Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma for Severe COVID-19
NCT04547660Phase 3Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jul 2020
- Primary completion
- Jan 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Hospital de Clínicas de Porto Alegre. Started Jul 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04547660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04547660.